Bradsaúde (SAUD3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jul, 2026Executive summary
Net operating revenue grew 5.3% year-over-year to R$2.39 billion, with an average ticket of R$22.23 per member per month and a net addition of 339,460 members, reaching 9.26 million beneficiaries at year-end, led by SME segment expansion.
Recurring net income for 2025 was R$550 million, up 4.1% over 2024, with an adjusted EBITDA margin of 31.0%.
Maintained a net cash position of R$713 million at year-end, with zero debt and strong cash generation.
Shareholder remuneration totaled R$456 million (83% payout), including dividends, interest on equity, and share buybacks.
Recognized for ESG leadership, ranked 19th globally and highest among Brazilian firms in TIME's 2026 World's Best Companies in Sustainable Growth.
Financial highlights
Adjusted EBITDA reached R$741 million in 2025, up 6.7% year-over-year, with margin expansion to 31.0%.
Net income of R$582.5 million, up 3.2% year-over-year.
Gross income: R$870.3 million, up from R$790.9 million in 2024.
Cost of services represented 38.9% of revenue, maintaining historic efficiency.
ROE stood at 43% for 2025.
Outlook and guidance
SME and Individual plans segment continues to drive growth, with a 12% CAGR in revenue since 2014 and higher average ticket than corporate segment.
Continued focus on digital initiatives and technology investments, with IT CAPEX of R$82 million in 2025.
Regulatory capital remains well above minimum requirements, supporting future growth.
Latest events from Bradsaúde
- Net income up 15% in 3Q24, with margin expansion and 100% payout to shareholders.SAUD3
Q3 20249 Jul 2026 - Net income was R$1.3B in 1Q26, with 13M+ members and major hospital and digital expansion.SAUD3
Q1 20268 Jul 2026 - Record SME growth and margin expansion drove strong revenue and net income gains.SAUD3
Q3 20256 Jul 2026 - Net income up 18.1% YoY, record EBITDA margin, and robust SME-driven growth.SAUD3
Q2 20256 Jul 2026 - Adjusted EBITDA margin rose to 38.3% in 1Q25, led by SME and Individual plan growth.SAUD3
Q1 20256 Jul 2026 - Revenue up 5.9%, net income R$539M, 97% payout, R$913M net cash, no debt.SAUD3
Q4 20242 Jul 2026 - 2Q24 delivered strong growth, record margins, and a 100% net income payout to shareholders.SAUD3
Q2 20242 Jul 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.SAUD3
Status update28 Jan 2026